Skip directly to page options Skip directly to A-Z link
Volume 29, Number 7—July 2023
Research

Systematic Review of Hansen Disease Attributed to Mycobacterium lepromatosis

Simon M. Collin, Amanda Lima, Stéfano Heringer, Vinícius Sanders, Hugo Aborghetti Pessotti, and Patrícia DepsComments to Author 
Author affiliation: Universidade Federal do Espírito Santo, Vitória, Espírito Santo, Brazil

Main Article

Table 2

Specimen surveys investigating Mycobacterium lepromatosis as a cause of Hansen disease*

Ref. Country (origin) Specimen date range Specimens PCR results
 HD types (remarks)
Neg Pos M. lepromatosis Dual infection M. leprae
(3) Mexico Not reported 64 type not reported 0 64 6 0 58 DLL 2
Venezuela Not reported 77 type not reported 0 77 0 0 77
Brazil Not reported 33 type not reported 0 33 0 0 33
Mali Not reported 48 type not reported 0 48 0 0 48
Others
 Not reported
 5 type not reported
 0
 5
 0
 0
 5
(6) Mexico Not reported 47 skin lesion biopsy 11 36 15 2 19
United States 2017 218 type not reported 146 72 3 0 69
Philippines 180 sss 0 180 0 0 180
United States (all but 1 born in Mexico)
 1968–1994
 15 skin biopsy sections
 0
 10
 5
 1
 4
 LL 2, DLL 4 (all originally from Mexico)
(33)
 Colombia†
 2006–2016
 67 skin lesion, 25 earlobe sss
 0
 92
 0
 5
 87
(34)
 Colombia (Cartagena, Bolívar)
 2015–2020
 41 skin biopsy
 7
 41
 0
 0
 34
(35)
 Mexico
 1988–2007
 120 skin biopsy
 33
 87
 55
 14
 18
 B 12, LL 41, DLL 16
(36) Brazil (Curitiba and southern Brazil) 2004–2010 52 skin biopsy 6 46 7 3 36 TT7, LL 3
Myanmar 2007–2008 9 skin biopsy 3 6 2 0 4 LL 2
Malaysia (19), Indonesia (3), Nepal (1), Myanmar (1) 2003–2011 31 skin biopsy 4 27 0 0 27
Uganda
 1979–1990
 4 skin biopsy
 2
 2
 0
 0
 2
(37)
 Mexico
 Current
19 skin biopsy
 9
 10
 2
 1
 7
 LL 2, not determined 1
(38)
 United States (various countries of origin)‡
 2011–2021
 38 tissue
 0
 38
 11
 0
 27
 LL 11 (all originally from Mexico)
(39)
 Mexico§
 1994–2014
 41 skin biopsy
 12
 29
 8
 8
 13
 BL 6, LL 6, DLL 4
(40)
 Mexico
 Current patients
 38 skin biopsy
 0
 38
 5
 0
 33
 BL 1, LL 1, DLL 3
(41)
 China
 Current patients
 171 skin biopsy
 86
 85
 0
 0
 85
(42) China (Shandong province) Not reported 85 skin biopsy 13 72 0 0 72

*B, borderline (BT, BB or BL); BB, mid-borderline (borderline borderline); BL, borderline lepromatous; BT, borderline tuberculoid; DLL, diffuse lepromatous leprosy; ENL, erythema nodosum leprosum (type 2 reaction); LL, lepromatous leprosy; LP, Lucio’s phenomenon (erythema necroticans); neg., negative; pos., positive; ref., reference; sss, skin slit smear; TT, tuberculoid. †Provinces of Atlántico, Antioquia, Bolívar, Chocó, Cesar, Cundinamarca, Magdalena, Santander, Norte de Santander, Sucre, and Tolima. ‡Mexico (22), Philippines (6), Vietnam (1), India (1), Myanmar (1), Marshall Islands (2), El Salvador (2), Brazil (1), United States (2). §Yucatan (16), Guerrero (8), Michoacán (6), Guanajuato (3), Morelos (2), 1 each from Campeche, Ciudad de Mexico, Estado de Mexico, Oaxaca, Puebla, and Quintana Roo.

Main Article

References
  1. Han  XY, Seo  YH, Sizer  KC, Schoberle  T, May  GS, Spencer  JS, et al. A new Mycobacterium species causing diffuse lepromatous leprosy. Am J Clin Pathol. 2008;130:856–64. DOIPubMedGoogle Scholar
  2. Han  XY, Sizer  KC, Thompson  EJ, Kabanja  J, Li  J, Hu  P, et al. Comparative sequence analysis of Mycobacterium leprae and the new leprosy-causing Mycobacterium lepromatosis. J Bacteriol. 2009;191:6067–74. DOIPubMedGoogle Scholar
  3. Singh  P, Benjak  A, Schuenemann  VJ, Herbig  A, Avanzi  C, Busso  P, et al. Insight into the evolution and origin of leprosy bacilli from the genome sequence of Mycobacterium lepromatosis. Proc Natl Acad Sci U S A. 2015;112:4459–64. DOIPubMedGoogle Scholar
  4. Silva  FJ, Santos-Garcia  D, Zheng  X, Zhang  L, Han  XY. Construction and analysis of the complete genome sequence of leprosy agent Mycobacterium lepromatosis. Microbiol Spectr. 2022;10:e0169221. DOIPubMedGoogle Scholar
  5. Avanzi  C, Singh  P, Truman  RW, Suffys  PN. Molecular epidemiology of leprosy: An update. Infect Genet Evol. 2020;86:104581. DOIPubMedGoogle Scholar
  6. Sharma  R, Singh  P, McCoy  RC, Lenz  SM, Donovan  K, Ochoa  MT, et al. Isolation of Mycobacterium lepromatosis and development of molecular diagnostic assays to distinguish Mycobacterium leprae and M. lepromatosis. Clin Infect Dis. 2020;71:e262–9. DOIPubMedGoogle Scholar
  7. Scollard  DM. Pathogenesis and pathology of leprosy. In: Scollard DM, Gillis TP, editors. International textbook of leprosy. 2018. https://www.internationaltextbookofleprosy.org/chapter/pathology
  8. Frade  MAC, Coltro  PS, Filho  FB, Horácio  GS, Neto  AA, da Silva  VZ, et al. Lucio’s phenomenon: A systematic literature review of definition, clinical features, histopathogenesis and management. Indian J Dermatol Venereol Leprol. 2022;88:464–77. DOIPubMedGoogle Scholar
  9. Romero-Navarrete  M, Arenas  R, Han  XY, Vega-Memije  ME, Castillo-Solana  AD. Leprosy caused by Mycobacterium lepromatosis. Am J Clin Pathol. 2022;158:678–86. DOIPubMedGoogle Scholar
  10. National Heart Lung and Blood Institute. Quality assessment tool for observational cohort and cross-sectional studies [cited 2019 May 24]. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools
  11. Norman  T, Zikry  J, Worswick  S, Kim  G, Ochoa  MT. Lucio phenomenon with concomitant necrotizing fasciitis and acute kidney injury. Dermatol Online J. 2022;28:28. DOIPubMedGoogle Scholar
  12. Bezalel  SA, Onajin  O, Gonzalez-Santiago  TM, Patel  R, Pritt  BS, Virk  A, et al. Leprosy in a midwestern dermatology clinic: report of 9 patients. Mayo Clin Proc. 2019;94:417–23. DOIPubMedGoogle Scholar
  13. Virk  A, Pritt  B, Patel  R, Uhl  JR, Bezalel  SA, Gibson  LE, et al. Mycobacterium lepromatosis lepromatous leprosy in US citizen who traveled to disease-endemic areas. Emerg Infect Dis. 2017;23:1864–6. DOIPubMedGoogle Scholar
  14. Beltrame  A, Barabino  G, Wei  Y, Clapasson  A, Orza  P, Perandin  F, et al. Leprosy in refugees and migrants in Italy and a literature review of cases reported in Europe between 2009 and 2018. Microorganisms. 2020;8:1113. DOIPubMedGoogle Scholar
  15. Trave  I, Barabino  G, Cavalchini  A, Parodi  A. Long-term ulcerations caused by Mycobacterium lepromatosis. Int J Mycobacteriol. 2020;9:223–5. DOIPubMedGoogle Scholar
  16. Vera-Cabrera  L, Escalante-Fuentes  WG, Gomez-Flores  M, Ocampo-Candiani  J, Busso  P, Singh  P, et al. Case of diffuse lepromatous leprosy associated with “Mycobacterium lepromatosis”. J Clin Microbiol. 2011;49:4366–8. DOIPubMedGoogle Scholar
  17. Han  XY, Sizer  KC, Tan  HH. Identification of the leprosy agent Mycobacterium lepromatosis in Singapore. J Drugs Dermatol. 2012;11:168–72.PubMedGoogle Scholar
  18. Jessamine  PG, Desjardins  M, Gillis  T, Scollard  D, Jamieson  F, Broukhanski  G, et al. Leprosy-like illness in a patient with Mycobacterium lepromatosis from Ontario, Canada. J Drugs Dermatol. 2012;11:229–33.PubMedGoogle Scholar
  19. Han  XY, Jessurun  J. Severe leprosy reactions due to Mycobacterium lepromatosis. Am J Med Sci. 2013;345:65–9. DOIPubMedGoogle Scholar
  20. Han  XY, Quintanilla  M. Diffuse lepromatous leprosy due to Mycobacterium lepromatosis in Quintana Roo, Mexico. J Clin Microbiol. 2015;53:3695–8. DOIPubMedGoogle Scholar
  21. Widiatma  RR, Sukanto  H. Diffuse lepromatous leprosy caused by dual infection of Mycobacterium leprae and Mycobacterium lepromatosis: a case report. Dermatol Rep. 2019;11:180–2. DOIGoogle Scholar
  22. Serrano-Coll  HA, Beltrán-Alzate  JC, Buitrago  SM, Cardona-Castro  N. Lepromatous leprosy and human immunodeficiency virus co-infection associated with phenomenon of Lucio versus immune reconstitution inflammatory syndrome. Infectio. 2016;20:272–5. DOIGoogle Scholar
  23. Sotiriou  MC, Stryjewska  BM, Hill  C. Two cases of leprosy in siblings caused by Mycobacterium lepromatosis and review of the literature. Am J Trop Med Hyg. 2016;95:522–7. DOIPubMedGoogle Scholar
  24. Velarde-Félix  JS, Alvarado-Villa  G, Vera-Cabrera  L. “Lucio’s phenomenon” associated with Mycobacterium lepromatosis. Am J Trop Med Hyg. 2016;94:483–4.PubMedGoogle Scholar
  25. Cleary  LC, Suraj  S, Haburchak  D, Turrentine  JE. The armadillo factor: lepromatous leprosy. Am J Med. 2017;130:1163–6. DOIPubMedGoogle Scholar
  26. Htet  L, Kai  M, Miyamoto  Y. New etiology of leprosy in Myanmar: another two patients. Lepr Rev. 2018;89:316–8. DOIGoogle Scholar
  27. Aldama Olmedo  OM, Escobar  M, Martínez  MJ, Aldama  M, Montoya Bueno  C, Celias  LF, et al. Necrotizing erythema nodosumin lepromatous leprosy associated with mixed infection by Mycobacterium lepromatosis and Mycobacterium leprae [in Spanish]. Rev Nac (Itauguá). 2020;12:107–15. DOIGoogle Scholar
  28. Oo  YM, Paez  A, Brown  R. Leprosy: A rare case of infectious peripheral neuropathy in the United States. IDCases. 2020;20:e00765. DOIPubMedGoogle Scholar
  29. Watson  W, Vassantachart  JM, Luke  J. Clinicopathological challenge: acute blistering and dermal papules in a patient with scleroderma. Int J Dermatol. 2020;59:e99–101. DOIPubMedGoogle Scholar
  30. Flores-Suárez  LF, Fernández-Sánchez  M, Ahumada-Topete  VH, Rodríguez  M, Charli-Joseph  Y. After all, still a magnificent impersonator. Rheumatology (Oxford). 2021;60:e245–6. DOIPubMedGoogle Scholar
  31. Fernández  JDP, Pou-Soarez  VE, Arenas  R, Juárez-Duran  ER, Luna-Rojas  SL, Xicohtencatl-Cortes  J, et al. Mycobacterium leprae and Mycobacterium lepromatosis infection: a report of six multibacillary cases of leprosy in the Dominican Republic. Jpn J Infect Dis. 2022;75:427–30. DOIPubMedGoogle Scholar
  32. Kumar  DP, Uprety  S, Dogra  S. Clinical diagnosis of leprosy. In: Scollard DM, Gillis TP, editors. International textbook of leprosy. 2018 [cited 2023 Jan 8]. https://www.internationaltextbookofleprosy.org/chapter/diagnosis-leprosy
  33. Cardona-Castro  N, Escobar-Builes  MV, Serrano-Coll  H, Adams  LB, Lahiri  R. Mycobacterium lepromatosis as cause of leprosy, Colombia. Emerg Infect Dis. 2022;28:1067–8. DOIPubMedGoogle Scholar
  34. Fragozo-Ramos  MC, Cano-Pérez  E, Sierra-Merlano  RM, Camacho-Chaljub  F, Gómez-Camargo  D. Clinical, histopathological, and molecular characterization of leprosy in an endemic area of the colombian caribbean. Int J Mycobacteriol. 2021;10:155–61.PubMedGoogle Scholar
  35. Han  XY, Sizer  KC, Velarde-Félix  JS, Frias-Castro  LO, Vargas-Ocampo  F. The leprosy agents Mycobacterium lepromatosis and Mycobacterium leprae in Mexico. Int J Dermatol. 2012;51:952–9. DOIPubMedGoogle Scholar
  36. Han  XY, Aung  FM, Choon  SE, Werner  B. Analysis of the leprosy agents Mycobacterium leprae and Mycobacterium lepromatosis in four countries. Am J Clin Pathol. 2014;142:524–32. DOIPubMedGoogle Scholar
  37. Kai  M, Fafutis-Morris  M, Miyamoto  Y, Mukai  T, Mayorga-Rodriguez  J, Rodriguez-Castellanos  MA, et al. Mutations in the drug resistance-determining region of Mycobacterium lepromatosis isolated from leprosy patients in Mexico. J Dermatol. 2016;43:1345–9. DOIPubMedGoogle Scholar
  38. Khan  S, Adler  BL, Armstrong  AW, Lahiri  R, Ochoa  MT. Impact of Mycobacterium leprae and Mycobacterium lepromatosis on immune reactions and clinical outcomes in Hansen’s disease: A single-center retrospective analysis. J Am Acad Dermatol. 2023;88:722–4. DOIPubMedGoogle Scholar
  39. Torres-Guerrero  E, Sánchez-Moreno  EC, Atoche-Diéguez  CE, Carrillo-Casas  EM, Arenas  R, Xicohtencatl-Cortes  J, et al. Identification of Mycobacterium leprae and Mycobacterium lepromatosis in formalin-fixed and paraffin-embedded skin samples from Mexico. Ann Dermatol. 2018;30:562–5. DOIPubMedGoogle Scholar
  40. Vera-Cabrera  L, Escalante-Fuentes  W, Ocampo-Garza  SS, Ocampo-Candiani  J, Molina-Torres  CA, Avanzi  C, et al. Mycobacterium lepromatosis Infections in Nuevo León, Mexico. J Clin Microbiol. 2015;53:1945–6. DOIPubMedGoogle Scholar
  41. Yuan  Y, Wen  Y, You  Y, Xing  Y, Li  H, Weng  X, et al. Characterization of Mycobacterium leprae genotypes in China—identification of a new polymorphism C251T in the 16S rRNA gene. PLoS One. 2015;10:e0133268. DOIPubMedGoogle Scholar
  42. Zhang  Y, Sun  Y, Wang  C, Liu  D, Chen  M, Fu  X, et al. Failure to detect Mycobacterium lepromatosis as a cause of leprosy in 85 Chinese patients. Indian J Dermatol Venereol Leprol. 2015;81:499–500. DOIPubMedGoogle Scholar
  43. Saúl  A, Novales  J. [Lucio-Latapí leprosy and the Lucio phenomenon]. Acta Leprol. 1983;1:115–32.PubMedGoogle Scholar
  44. Vargas-Ocampo  F. Diffuse leprosy of Lucio and Latapí: a histologic study. Lepr Rev. 2007;78:248–60. DOIPubMedGoogle Scholar
  45. World Health Organization. The Global Health Observatory. Geneva: The Organization; 2022 [cited 2023 Jan 8]. https://www.who.int/data/gho
  46. Larrea  MR, Carreño  MC, Fine  PE. Patterns and trends of leprosy in Mexico: 1989-2009. Lepr Rev. 2012;83:184–94. DOIPubMedGoogle Scholar
  47. Aubry  A, Sammarco Rosa  P, Chauffour  A, Fletcher  ML, Cambau  E, Avanzi  C. Drug resistance in leprosy: An update following 70years of chemotherapy. Infect Dis Now. 2022;52:243–51. DOIPubMedGoogle Scholar
  48. Deps  P, Antunes  JMAP, Collin  SM. Zoonotic risk of Hansen’s disease from community contact with wild armadillos: A systematic review and meta-analysis. Zoonoses Public Health. 2021;68:153–64. DOIPubMedGoogle Scholar
  49. Avanzi  C, Del-Pozo  J, Benjak  A, Stevenson  K, Simpson  VR, Busso  P, et al. Red squirrels in the British Isles are infected with leprosy bacilli. Science. 2016;354:744–7. DOIPubMedGoogle Scholar
  50. Deps  P, Collin  SM. Mycobacterium lepromatosis as a second agent of Hansen’s disease. Front Microbiol. 2021;12:698588. DOIPubMedGoogle Scholar

Main Article

Page created: May 22, 2023
Page updated: June 20, 2023
Page reviewed: June 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external